![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 21592 |
FusionGeneSummary for MEF2A_WDR61 |
![]() |
Fusion gene information | Fusion gene name: MEF2A_WDR61 | Fusion gene ID: 21592 | Hgene | Tgene | Gene symbol | MEF2A | WDR61 | Gene ID | 4205 | 80349 |
Gene name | myocyte enhancer factor 2A | WD repeat domain 61 | |
Synonyms | ADCAD1|RSRFC4|RSRFC9|mef2 | REC14|SKI8 | |
Cytomap | 15q26.3 | 15q25.1 | |
Type of gene | protein-coding | protein-coding | |
Description | myocyte-specific enhancer factor 2AMADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)serum response factor-like protein 1 | WD repeat-containing protein 61SKI8 homologmeiotic recombination REC14 protein homologrecombination protein REC14 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q02078 | Q9GZS3 | |
Ensembl transtripts involved in fusion gene | ENST00000453228, ENST00000354410, ENST00000558856, ENST00000558812, ENST00000338042, ENST00000557785, ENST00000449277, ENST00000557942, | ENST00000559332, ENST00000558311, ENST00000267973, ENST00000558459, | |
Fusion gene scores | * DoF score | 5 X 6 X 4=120 | 3 X 3 X 2=18 |
# samples | 6 | 5 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/18*10)=1.47393118833241 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: MEF2A [Title/Abstract] AND WDR61 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MEF2A | GO:0000122 | negative regulation of transcription by RNA polymerase II | 16484498 |
Hgene | MEF2A | GO:0000165 | MAPK cascade | 9858528 |
Hgene | MEF2A | GO:0006351 | transcription, DNA-templated | 16043483 |
Hgene | MEF2A | GO:0010613 | positive regulation of cardiac muscle hypertrophy | 24161931 |
Hgene | MEF2A | GO:0045944 | positive regulation of transcription by RNA polymerase II | 7760790|9858528|10748098|15466416|20590529|21468593 |
Hgene | MEF2A | GO:0071277 | cellular response to calcium ion | 16484498 |
Tgene | WDR61 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 20178742 |
Tgene | WDR61 | GO:0045638 | negative regulation of myeloid cell differentiation | 20541477 |
Tgene | WDR61 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20178742 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SKCM | TCGA-GN-A26A-06A | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000453228 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
intron-5UTR | ENST00000453228 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
intron-5UTR | ENST00000453228 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
intron-5UTR | ENST00000453228 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-intron | ENST00000354410 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000354410 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000354410 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000354410 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
3UTR-intron | ENST00000558856 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
3UTR-5UTR | ENST00000558856 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
3UTR-5UTR | ENST00000558856 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
3UTR-5UTR | ENST00000558856 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-intron | ENST00000558812 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000558812 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000558812 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000558812 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-intron | ENST00000338042 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000338042 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000338042 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000338042 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-intron | ENST00000557785 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000557785 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000557785 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000557785 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-intron | ENST00000449277 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000449277 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000449277 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000449277 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-intron | ENST00000557942 | ENST00000559332 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000557942 | ENST00000558311 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000557942 | ENST00000267973 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
5UTR-5UTR | ENST00000557942 | ENST00000558459 | MEF2A | chr15 | 100106309 | + | WDR61 | chr15 | 78588067 | - |
Top |
FusionProtFeatures for MEF2A_WDR61 |
![]() |
Hgene | Tgene |
MEF2A | WDR61 |
Component of the PAF1 complex (PAF1C) which has multiplefunctions during transcription by RNA polymerase II and isimplicated in regulation of development and maintenance ofembryonic stem cell pluripotency. PAF1C associates with RNApolymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms andis involved in transcriptional elongation, acting bothindepentently and synergistically with TCEA1 and in cooperationwith the DSIF complex and HTATSF1. PAF1C is required fortranscription of Hox and Wnt target genes. PAF1C is involved inhematopoiesis and stimulates transcriptional activity ofKMT2A/MLL1; it promotes leukemogenesis through association withKMT2A/MLL1-rearranged oncoproteins, such as KMT2A/MLL1-MLLT3/AF9and KMT2A/MLL1-MLLT1/ENL. PAF1C is involved in histonemodifications such as ubiquitination of histone H2B andmethylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits theRNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzymeUBE2A or UBE2B to chromatin which mediate monoubiquitination of'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2Bubiquitination is proposed to be coupled to transcription. PAF1Cis involved in mRNA 3' end formation probably through associationwith cleavage and poly(A) factors. In case of infection byinfluenza A strain H3N2, PAF1C associates with viral NS1 protein,thereby regulating gene transcription. Required for mono- andtrimethylation on histone H3 'Lys-4' (H3K4me3), dimethylation onhistone H3 'Lys-79' (H3K4me3). Required for Hox genetranscription. Component of the SKI complex which is thought to beinvolved in exosome-mediated RNA decay and associates withtranscriptionally active genes in a manner dependent on PAF1C.{ECO:0000269|PubMed:16024656, ECO:0000269|PubMed:16307923,ECO:0000269|PubMed:19952111, ECO:0000269|PubMed:20178742}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MEF2A_WDR61 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MEF2A_WDR61 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MEF2A | VGLL4, HDAC4, HDAC9, THRA, EP300, HDAC5, SMAD2, MAPK14, ASCL1, MYOG, MAPK7, MEF2D, ACTN4, HDAC7, HDAC1, HNRNPA1, UBE2I, PHB2, ERBB2IP, DDB1, NDUFB9, GNB2, GNG12, TBP, TAF8, HDAC3, HAND1, XPO1, KLC4, JUN, ATF3, ATF7, CABIN1, HIST1H2BA, MEF2C, HIRA, REV3L, SH2B1, HIST1H2BC, HIST3H3, JUND, CCDC15, MAPKAPK3, SETX, TTLL7, ZCWPW1, ITGB1, MEF2B, XYLT1, DNMT3L, TSR3 | WDR61 | EZH2, MLH1, CUL4A, CUL4B, WDR5, KMT2A, PAF1, TCEA1, CTR9, RTF1, CDC73, LEO1, HIST1H3A, PTPN11, COPS5, USH1C, UCHL5, UBA3, UBE2K, BARD1, BIRC3, YWHAQ, HK1, HK2, PLCG1, PYGB, RARS, RIC8A, DPP7, HEXA, SARNP, ASB15, CIAO1, HIST1H1A, HIST1H1C, DDX3X, DNAJC2, ERCC2, RNF40, ATP6V1B2, IFI16, XPO1, SUPT5H, ERRFI1, PPP2CA, PPP2CB, MCPH1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MEF2A_WDR61 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MEF2A_WDR61 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MEF2A | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Hgene | MEF2A | C0349204 | Nonorganic psychosis | 1 | PSYGENET |